May 21, 2012
News outlets report on efforts to address the cost of drugs for HIV/AIDS as well as other related developments.
The Washington Post: "Radical" Bill Seeks to Reduce Cost Of AIDS Drugs by Awarding Prizes Instead of Patents
Prizes, not patents. That could be the slogan for a radical idea that leading economists say would lower the price of new drugs for treating HIV/AIDS (Vastag, 5/19).
CQ HealthBeat: U.S. Continues Action On AIDS Drugs, Testing As July Global Summit Nears
As Washington prepares for a major international AIDS conference this summer, developments on the drug front are once again elevating the subject of the continuing epidemic in the public eye. Advisory panels recommended recently that the Food and Drug Administration approve both a drug to prevent the HIV infection and an at-home diagnostic kit. Also, Sen. Bernard Sanders is offering a way to reduce the steep costs of drug treatments for people with HIV and AIDS (Norman, 5/18).
This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.